ロード中...
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer
LESSONS LEARNED. This clinical trial, evaluating the efficacy and safety of a carboplatin plus paclitaxel regimen in a biweekly or weekly schedule instead of the more toxic 3‐weekly administration, showed that the weekly regimen was better in efficacy than the biweekly regimen, with mild toxicities,...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853129/ https://ncbi.nlm.nih.gov/pubmed/31332099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0513 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|